Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 16/20 | 0.61 |
| ▸ | P2RY4 | P51582 | 10/20 | 0.61 |
| ▸ | POLA1 | P09884 | 1/20 | 0.58 |
| ▸ | P2RY6 | Q15077 | 7/20 | 0.58 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL661070 | 1.00 | P2RY2 (0.61) | P2RY2P2RY4POLA1P2RY6P2RY14 | |
| SCHEMBL22110865 | 1.00 | P2RY2 (0.61) | P2RY2P2RY4POLA1P2RY6P2RY14 | |
| SCHEMBL1501001 | 1.00 | P2RY2 (0.61) | P2RY2P2RY4POLA1P2RY6P2RY14 | |
| SCHEMBL9279845 | 0.98 | P2RY6 (0.58) | P2RY2P2RY4POLA1P2RY6P2RY14 | |
| SCHEMBL18427659 | 0.91 | P2RY2 (0.52) | P2RY2P2RY4POLA1P2RY6 | |
| SCHEMBL16807583 | 0.90 | P2RY2 (0.61) | P2RY2P2RY4POLA1P2RY6P2RY14 | |
| SCHEMBL21346154 | 0.90 | P2RY2 (0.59) | P2RY2P2RY4POLA1P2RY6P2RY14 | |
| SCHEMBL533609 | 0.89 | DUT (0.53) | P2RY2P2RY4P2RY6P2RY14 | |
| SCHEMBL20879422 | 0.89 | DUT (0.53) | P2RY2P2RY4P2RY6P2RY14 | |
| SCHEMBL29264470 | 0.89 | DUT (0.53) | P2RY2P2RY4P2RY6P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3131914-B1 | 3'-SUBSTITUTED METHYL OR ALKYNYL NUCLEOSIDES FOR THE TREATMENT OF HCV | IDENIX PHARMACEUTICALS LLC (US) | 2023-05-10 | — | — | EP | disclosed |